Skip to content

Rhythm Pharmaceuticals

US · RYTM #1874 by market cap Listed 2017
112.36 -4.44 -3.80%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Quant vs Street three independent views, side by side

StockVane factor grade
B
Momentum strategy signal
Hold
Analyst consensus
Buy

Mostly aligned, one view stands apart.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

Analyst consensus 15 analysts

Buy
Avg price target 149.64 +33.2%
Price target rangecurrent 112.36
Low120.00
Avg149.64
High206.00
Buy 93% Hold 7% Sell 0%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-11-06 J.P. Morgan -- Buy 142.00
2026-11-05 CCORF -- Buy 168.00
2026-11-05 Citi -- Buy 143.00
2026-11-04 Wells Fargo -- Buy 155.00
2026-11-04 Citizens JMP -- Buy 166.00
2026-11-04 Morgan Stanley -- Buy 146.00
2026-11-04 Guggenheim -- Buy 147.00
2026-11-03 TD Cowen -- Buy 130.00
2026-11-03 BofA Securities -- Buy 150.00
2026-11-03 RBC Capital -- Buy 159.00
2026-10-28 Citi -- Buy 143.00
2026-10-19 Guggenheim -- Buy 143.00
2026-10-15 William Blair -- Buy 206.00
2026-10-15 J.P. Morgan -- Buy 145.00
2026-10-14 Citi -- Buy 143.00
2026-10-12 H.C. Wainwright -- Buy 130.00
2026-10-09 BofA Securities -- Buy --
2026-10-08 RBC Capital -- Buy 159.00
2026-09-17 Wolfe Research -- Buy --
2026-09-15 J.P. Morgan -- Buy --
2026-09-14 Leerink Partners -- Buy 133.00
2026-09-14 RBC Capital -- Buy 155.00
2026-08-27 Deutsche Bank -- Hold 120.00
2026-08-24 Morgan Stanley -- Buy 150.00
2026-08-24 Guggenheim -- Buy 143.00

Price target trend monthly average, last 3 years

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2026/Q3 2026-11-03 -- ±10.53% -7.49% (in line)
2026/Q2 2026-08-04 -- ±11.25% +2.92% (in line)
2026/Q1 2026-05-05 -- ±11.16% +7.86% (in line)
2025/Q4 2026-02-26 -- ±14.17% -1.09% (in line)
2025/Q3 2025-11-04 -- ±9.68% -7.69% (in line)
2025/Q2 2025-08-05 -- ±9.45% -1.85% (in line)
2025/Q1 2025-05-07 -- ±12.54% +3.06% (in line)
2024/Q4 2025-02-26 -- ±10.15% +4.49% (in line)
2024/Q3 2024-11-05 After close ±8.36% +11.38% (beat)
2024/Q2 2024-08-06 -- ±25.32% +0.02% (in line)
2024/Q1 2024-05-07 -- ±8.75% -10.32% (beat)
2023/Q4 2024-02-22 -- ±15.48% -9.73% (in line)

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Rhythm Pharmaceuticals discussion 0 comments

Add a comment